Molecular diagnostics maker Exact Sciences Corp. submitted data from the DeeP-C clinical trial June 7 for its Cologuard stool colorectal screening test, completing the company’s modular PMA application, and paving the way to request Medicare coverage through the FDA-CMS parallel review process.
The DeeP-C trial